{"annotatable":{"parts":["s1v1","s2v1","s3v1","s4v1","s5v1","s6v1","s7v1","s8v1","s9v1","s10v1","s11v1","s12v1","s13v1","s14v1","s15v1","s16v1","s17v1","s18v1","s19v1","s20v1","s21v1","s22v1","s23v1","s24v1","s25v1","s26v1","s27v1","s28v1","s29v1","s30v1","s31v1"]},"anncomplete":true,"sources":[],"metas":{},"entities":[{"classId":"e_1","part":"s4v1","offsets":[{"start":3073,"text":"A SAS procedure (PROC PLAN) was used to generate the random allocation sequence."}],"coordinates":[{"x":"200.01","y":"567.36"},{"x":"545.85","y":"571.86"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_4","part":"s4v1","offsets":[{"start":3270,"text":"The random sequence was imported to a data management system owned and administrated by an investigative drug service company (Almac’s WebEZ system) and blinded to study investigators."}],"coordinates":[{"x":"275.53","y":"593.38"},{"x":"319.61","y":"623.85"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_11","part":"s4v1","offsets":[{"start":3633,"text":"Interventions were known to the investigator and patients."}],"coordinates":[{"x":"288.05","y":"645.37"},{"x":"520.59","y":"649.87"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_14","part":"s4v1","offsets":[{"start":3633,"text":"Interventions were known to the investigator and patients."}],"coordinates":[{"x":"288.05","y":"645.37"},{"x":"520.59","y":"649.87"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_38","part":"s4v1","offsets":[{"start":3633,"text":"Interventions were known to the investigator and patients."}],"coordinates":[{"x":"288.05","y":"645.37"},{"x":"520.59","y":"649.87"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_30","part":"s6v1","offsets":[{"start":662,"text":"The primary outcome was a healthy birth outcome defined as defined as a live birth of an infant born at �37 weeks, with a birth weight between 2,500 and 4,000 g and without a major congenital anomaly."}],"coordinates":[{"x":"200.01","y":"221.59"},{"x":"280.50","y":"252.06"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_32","part":"s6v1","offsets":[{"start":662,"text":"The primary outcome was a healthy birth outcome defined as defined as a live birth of an infant born at �37 weeks, with a birth weight between 2,500 and 4,000 g and without a major congenital anomaly."}],"coordinates":[{"x":"200.01","y":"221.59"},{"x":"280.50","y":"252.06"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_33","part":"s6v1","offsets":[{"start":662,"text":"The primary outcome was a healthy birth outcome defined as defined as a live birth of an infant born at �37 weeks, with a birth weight between 2,500 and 4,000 g and without a major congenital anomaly."}],"coordinates":[{"x":"200.01","y":"221.59"},{"x":"280.50","y":"252.06"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_35","part":"s6v1","offsets":[{"start":662,"text":"The primary outcome was a healthy birth outcome defined as defined as a live birth of an infant born at �37 weeks, with a birth weight between 2,500 and 4,000 g and without a major congenital anomaly"}],"coordinates":[{"x":"200.01","y":"221.59"},{"x":"278.25","y":"252.06"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_39","part":"s6v1","offsets":[{"start":662,"text":"The primary outcome was a healthy birth outcome defined as defined as a live birth of an infant born at �37 weeks, with a birth weight between 2,500 and 4,000 g and without a major congenital anomaly."}],"coordinates":[{"x":"200.01","y":"221.59"},{"x":"280.50","y":"252.06"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_41","part":"s6v1","offsets":[{"start":662,"text":"The primary outcome was a healthy birth outcome defined as defined as a live birth of an infant born at �37 weeks, with a birth weight between 2,500 and 4,000 g and without a major congenital anomaly."}],"coordinates":[{"x":"200.01","y":"221.59"},{"x":"280.50","y":"252.06"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_21","part":"s6v1","offsets":[{"start":2181,"text":"The primary analyses used an intent-to-treat principle, wherein all randomized patients were analyzed according to their randomized treatment assignment, regardless of the actual treatment they received, protocol violations, or dropouts for the primary outcome."}],"coordinates":[{"x":"211.97","y":"480.05"},{"x":"527.29","y":"510.52"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_13","part":"s6v1","offsets":[{"start":3425,"text":"A total of 40 of 191(20.9%) women withdrew from the stan- dard lifestyle group and 31 of 188 (16.5%) from the intensive group (P = 0.267)."}],"coordinates":[{"x":"339.02","y":"691.52"},{"x":"514.88","y":"709.00"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_19","part":"s6v1","offsets":[{"start":3564,"text":"There were no"}],"coordinates":[{"x":"517.09","y":"704.50"},{"x":"574.67","y":"709.00"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_26","part":"s7v1","offsets":[{"start":0,"text":"Fig 1. Flowchart: Enrollment and outcomes of the trial. aOne had a history of or suspected cervical/endometrial/or breast carcinoma; 1 had known Cushing disease, known or suspected adrenal or ovarian secreting tumors, or a history of gout; 1 had a history of alcohol abuse; 1 had an"}],"coordinates":[{"x":"108.45","y":"692.70"},{"x":"561.76","y":"705.83"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_19","part":"s8v1","offsets":[{"start":0,"text":"significant differences between groups for reasons of study withdrawal (S1–S8 Tables)."}],"coordinates":[{"x":"200.01","y":"213.03"},{"x":"542.88","y":"217.53"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_26","part":"s8v1","offsets":[{"start":2942,"text":"allergy, known hypersensitivity, or contraindication to the treatment medications; 1 had a presence of severe, untreated psychiatric illness; 1 had medical conditions that would be contraindicated to Orlistat, 1 had contraindication to study requirements including diet recommendation and activity requirements; 1 currently participating in lifestyle intervention program; and 1 in a period of acute weight loss or lost more than 5% body weight within the last 6 months. One participant or her male partner had previous sterilization procedures; 1 participant or her partner legally married to someone else; 1 using donated semen; and 1 have had pelvic radiation. bOne borderline HgA1C, 1 diagnosed with pulmonary embolism; 1 no response to Clomid; 1 patient developed a large complex cyst; 1 persistent cyst unable to start CC/IUI cycle; and 1 did not want to return for end of study visit. cOne patient had persistent ovarian cyst greater than 3 cm in size; 1 patient refused to see mental health provider regarding suicidal ideation; 1 PI discontinued patient from study; 1 patient’s spouse did not have adequate amount of sperm for IUI; and 1 husband did not want to proceed. dIncluding 1 patient who withdrew the study due to the borderline HgA1C and later achieved pregnancy and delivered live twin babies. BAU : AnabbreviationlisthasbeencompiledforthoseusedthroughoutFig1:Pleaseverifythatallentriesarecorrect:MI, body mass ndex; CC/IUI, clomi h ne citrat /intrauterine insemination; hCG, human chorioni gonadotropin; HgA1C, hemoglobin A1c; PI, principal investigator."}],"coordinates":[{"x":"108.45","y":"79.68"},{"x":"204.83","y":"178.30"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_8","part":"s9v1","offsets":[{"start":0,"text":"Table 1. Baseline characteristics of the patients.\n\nStandard lifestyle\n\nIntensive lifestyle\n\nDemographic\n\nAge (y)\n\n191\n\n188\n\n32.4 ± 4.0\n\n32.1 ± 4.5\n\n32.0 (30.0 to 35.0)\n\n32.0 (29.0 to 35.0)\n\nLevel of education\n\nHigh school graduate or less\n\n19/191 (9.9%)\n\n20/188 (10.6%)\n\nCollege graduate or some college\n\n134/191 (70.2%)\n\n138/188 (73.4%)\n\nGraduate degree\n\n38/191 (19.9%)\n\n30/188 (16.0%)\n\nEthnicity\n\nNot Hispanic or Latino\n\n177/191 (92.7%)\n\n179/188 (95.2%)\n\nHispanic or Latino\n\n9/191 (4.7%)\n\n3/188 (1.6%)\n\nUnknown\n\n5/191 (2.6%)\n\n6/188 (3.2%)\n\nRace\n\nWhite\n\n140/191 (73.3%)\n\n126/188 (67.0%)\n\nBlack\n\n37/191 (19.4%)\n\n45/188 (23.9%)\n\nAsian\n\n3/191 (1.6%)\n\n4/188 (2.1%)\n\nAmerican Indian or Alaska Native\n\n2/191 (1.0%)\n\n2/188 (1.1%)\n\nNative Hawaiian or other Pacific Islander\n\n0/191 (0.0%)\n\n0/188 (0.0%)\n\nUnknown\n\n4/191 (2.1%)\n\n5/188 (2.7%)\n\nMixed race\n\n5/191 (2.6%)\n\n6/188 (3.2%)\n\nHow long has the patient been attempting conception (months)?\n\n188\n\n187\n\n39.1 ± 33.0\n\n38.7 ± 28.6\n\n25.0 (16.5 to 48.0)\n\n24.0 (18.0 to 48.0)\n\nPrior live birth\n\n70/191 (36.6%)\n\n57/187 (30.5%)\n\nCurrent smoker\n\n16/191 (8.4%)\n\n16/188 (8.5%)\n\nWeight (kg)\n\n191\n\n187\n\n107.4 ± 20.8\n\n108.4 ± 22.7\n\n106.3 (91.8 to 119.9)\n\n105.0 (92.9 to 120.3)\n\nBMI at baseline (kg/m2)\n\n191\n\n188\n\n39.4 ± 6.9\n\n39.2 ± 7.0\n\n38.1 (33.9 to 44.3)\n\n37.8 (33.6 to 43.4)\n\nWaist circumference at baseline (cm)\n\n191\n\n188\n\n115.3 ± 15.6\n\n115.6 ± 15.6\n\n114.0 (103.5 to 125.0)\n\n113.0 (104.1 to 123.5)\n\nSystolic blood pressure (mmHg)\n\n189\n\n187\n\n123.3 ± 11.4\n\n123.7 ± 12.6\n\n122.0 (116.0 to 131.0)\n\n124.0 (115.0 to 131.0)\n\nDiastolic blood pressure (mm Hg)\n\n190\n\n187\n\n79.8 ± 10.6\n\n80.0 ± 9.9\n\n80.0 (74.0 to 87.0)\n\n81.0 (74.0 to 86.0)\n\nAverage steps per day at baseline (steps)\n\n189\n\n187\n\n6,945 ± 2,770\n\n6,723 ± 2,501\n\n6,635 (4,845 to 8,708)\n\n6,260 (4,869 to 8,091)"}],"coordinates":[{"x":"36.00","y":"79.68"},{"x":"540.34","y":"635.58"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_8","part":"s10v1","offsets":[{"start":0,"text":"Table 1. (Continued)\n\nStandard lifestyle\n\nIntensive lifestyle\n\n18.5 (12.1 to 30.8)\n\n20.7 (13.3 to 33.1)\n\nSHBG (nmol/L)\n\n190\n\n185\n\n35.8 ± 18.9\n\n39.0 ± 19.9\n\n32.9 (23.6 to 43.4)\n\n34.3 (25.9 to 48.4)\n\nFasting glucose (mg/dL)\n\n190\n\n185\n\n95.4 ± 14.3\n\n94.0 ± 13.6\n\n92.4 (84.7 to 104.2)\n\n91.8 (85.3 to 99.3)\n\nFasting insulin (uIU/mL)\n\n188\n\n185\n\n17.9 ± 20.7\n\n19.3 ± 16.9\n\n14.0 (9.1 to 19.8)\n\n14.7 (9.5 to 22.8)\n\nLeptin (ng/mL)\n\n190\n\n185\n\n77.9 ± 49.7\n\n79.9 ± 49.8\n\n62.2 (44.6 to 85.7)\n\n66.1 (48.5 to 86.2)\n\nHbA1c (%)\n\n172\n\n169\n\n5.5 ± 0.4\n\n5.4 ± 0.4\n\n5.4 (5.2 to 5.7)\n\n5.4 (5.2 to 5.6)\n\nAdiponectin (ng/mL)\n\n190\n\n185\n\n12,517 ± 8,323.9\n\n11,409 ± 6,969.8\n\n10,518 (6,909.4 to 15,634)\n\n9,746.6 (6,536.0 to 13,963) hs-CRP (mg/L)\n\n189\n\n185\n\n7.5 ± 6.4\n\n9.9 ± 13.7\n\n5.7 (2.8 to 10.1)\n\n6.2 (2.9 to 13.1)\n\nTotal cholesterol (mg/dL)\n\n183\n\n176\n\n186.8 ± 35.0\n\n187.3 ± 33.9\n\n183.0 (161.0 to 210.0)\n\n183.5 (165.5 to 210.0)\n\nTriglycerides (mg/dL)\n\n183\n\n176\n\n128.8 ± 62.5\n\n130.0 ± 59.2\n\n118.0 (83.0 to 158.0)\n\n117.0 (90.5 to 157.0)\n\nHDL cholesterol (mg/dL)\n\n183\n\n176\n\n40.3 ± 9.0\n\n40.1 ± 8.4\n\n39.0 (34.0 to 46.0)\n\n39.5 (33.5 to 45.0)\n\nIntegrated biometric and biochemical\n\nMetabolic syndrome\n\n98/183 (53.6%)\n\n93/176 (52.8%)\n\nQuestionnaire\n\nTotal score of fertility QoLa\n\n188\n\n184\n\n75.7 ± 13.1\n\n78.0 ± 12.6\n\n77.1 (66.7 to 85.9)\n\n80.7 (69.8 to 87.5)\n\nMale partner\n\nAge (y), maleb\n\n191\n\n187\n\n34.9 ± 5.8\n\n33.5 ± 5.3\n\n35.0 (30.0 to 39.0)\n\n33.0 (30.0 to 37.0)\n\nBMI (kg/m2), male\n\n191\n\n188\n\n32.8 ± 7.5\n\n32.5 ± 7.7\n\n32.3 (26.9 to 37.2)\n\n30.9 (27.5 to 36.0)\n\nTotal motile sperm (million)\n\n191\n\n188\n\n86.4 ± 154.6\n\n77.7 ± 85.3"}],"coordinates":[{"x":"36.00","y":"79.91"},{"x":"523.39","y":"676.01"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_8","part":"s11v1","offsets":[{"start":3912,"text":"Continuous variables are shown as n (top), mean ± SD (middle), and median (interquartile range) (bottom). Categorical variables are shown as no./total n (%).\n\naScore ranges from 0 to 100, with higher scores indicating better quality of life.\n\nbP = 0.025 for the comparison between the 2 groups.\n\nBMI, body mass index; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; hs-CRP, high-sensitivity C-reactive protein; QoL, Quality of Life; SHBG, sex hormone–binding globulin."}],"coordinates":[{"x":"36.00","y":"128.66"},{"x":"125.45","y":"180.23"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_24","part":"s14v1","offsets":[{"start":832,"text":"29/191 (15.2%)\n\n23/188 (12.2%)"}],"coordinates":[{"x":"211.29","y":"107.01"},{"x":"354.05","y":"110.61"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_44","part":"s25v1","offsets":[{"start":753,"text":"Rate of Good Birth Outcomes [ Time Frame: At time of birth, approximately 17 months into the study ]"}],"coordinates":[{"x":"60.50","y":"294.16"},{"x":"532.40","y":"301.25"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_45","part":"s25v1","offsets":[{"start":753,"text":"Rate of Good Birth Outcomes [ Time Frame: At time of birth, approximately 17 months into the study ]\n\nDefined as a live birth of an infant born at ≥ 37 weeks, with a birth weight between 2500 and 4000g and without a major congenital anomaly"}],"coordinates":[{"x":"60.50","y":"294.16"},{"x":"230.03","y":"343.25"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}}],"relations":[]}